Abstract:Abstract Background: Breath analysis is a promising noninvasive screening technique that offers a wide range of probable possibilities to facilitate early diagnosis of lung cancer (LC). Method: Exhaled breath samples of 352 subjects were analyzed to detect C6∼C30 VOCs through thermal desorption coupled with gas chromatography-mass spectrometry (TD-GC-MS). Data were divided into three categories Lung Cancer (LC), Benign Pulmonary Disease (BPD) and Healthy control (HC). Statistical classification models were used to analyze VOCs to distinguish between HC, BPD and LC patient's early and advanced stages. Receiver operator characteristics (ROC) curves were used to select different VOCs to evaluate the accuracy, specificity, and sensitivity of the diagnostic model. Results: The analysis resulted that 10,9,11 and 10 VOCs have a significant correlation to discriminate Histology, stage, BPD from LC and HC from LC. The diagnostic model predicted accuracy, sensitivity, and specificity of NSCLC vs. SCLC is 92%, 96% and 90% with area under curve AUC>0.913. As of ROC curve with AUC>0.819 has distinguished Stage I-II vs. stage III-IV with accuracy, sensitivity, and specificity 72%, 84%, and 80%. Whereas the ROC curve with AUC>0.795 has distinguished BPD from LC with accuracy, sensitivity, and specificity 83%, 89%, and 84%. While ROC curve with AUC>0.945, accuracy, sensitivity and specificity 92%, 96%, and 90% have distinguished HC from LC. Conclusion: This study confirms that TD GC-MS is a sensitive and dependable method to distinguish the VOCs in exhaled breath. We have witnessed significant differences in breath of BPD, HC and LC subjects. Where 10,8,11 and 10 VOCs have distinguished between early from the advance stage, NSCLC from SCLC, BPD from LC and HC from LC. These VOCs has the potential to help improve LC diagnosis and prognosis. However, with the expansion of multi centers to other regions could result in more vital findings and will help improve breath analysis and the diagnosis standard. Keywords: Breath Analysis, VOC markers, lung cancer, TD-GC-MS. Citation Format: Kanhar Ghulam Muhammad, Channa Madeeha, Fu Wei, Xu Lin Xin, Yanjie Hu, Kejing Ying, Jun Liu, Xing Chen. Volatile organic compounds (VOCs) from exhaled Breath for lung cancer Staging using TD-GC-MS [abstract]. In: Proceedings of the Annual Meeting of the American Association for Cancer Research 2020; 2020 Apr 27-28 and Jun 22-24. Philadelphia (PA): AACR; Cancer Res 2020;80(16 Suppl):Abstract nr 744.

Unlocking the Secrets: Volatile Organic Compounds (VOCs) and their Devastating Effects on Lung Cancer

Abstract 744: Volatile Organic Compounds (vocs) from Exhaled Breath for Lung Cancer Staging Using TD-GC-MS

[Determination of Volatile Organic Compounds in Lung Cancer Cell Lines and Lung Cancer Tissue].

A Study of the Volatile Organic Compounds Exhaled by Lung Cancer Cells in Vitro for Breath Diagnosis

Optimization of Volatile Markers of Lung Cancer to Exclude Interferences of Non-Malignant Disease

The research on early detection of lung cancer with exhaled volatile organic compounds

[Measurement of Exhaled Volatile Organic Compounds in Lung Cancer Patients].

Volatile organic compound exposure in relation to lung cancer: Insights into mechanisms of action through metabolomics

Diagnosis and Correlation Analysis of Lung Cancer Based on Multi-Parameter Regression of Respiratory Volatile Organic Compounds

Digging deeper into volatile organic compounds associated with cancer

Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.

Analyses of lung cancer-derived volatiles in exhaled breath and in vitro models

Critical Review of Volatile Organic Compound Analysis in Breath and In Vitro Cell Culture for Detection of Lung Cancer

Exhaled VOC detection in lung cancer screening: a comprehensive meta-analysis

LC-MS/MS Based Volatile Organic Compound Biomarkers Analysis for Early Detection of Lung Cancer

Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection

Detection of lung cancer with volatile organic biomarkers in exhaled breath and lung cancer cells

Evolving burden of lung cancer attributable to occupational carcinogens in 38 OECD countries: Global, national differences, age dynamics and implications for global health.

Associations between residential exposure to volatile organic compounds (VOCs) and liver injury markers

Volatile Organic Compounds Emission from Building Sector and Its Adverse Effects on Human Health

Volatile Organic Compounds in Exhaled Breath as Fingerprints of Lung Cancer, Asthma and COPD